Sumali Bajaj

Previous study and work experience: I completed my undergraduate degree in Statistics at University of Delhi (2010-13) and pursued my interest in research by undertaking a range of independent projects at the Indian Institute of Technology-Delhi, the All India Institute of Medical Sciences and Public Health Foundation of India. I then completed my graduate degree program in Biostatistics at the Harvard T.H Chan School of Public Health (HSPH) (2015-17). Since 2017 I've been working as a research assistant at the Department of Infectious Disease Epidemiology at Imperial College London. First developing a hierarchical Bayesian model-based method for joint small area estimation of HIV prevalence and anti-retroviral therapy coverage at sub-national levels. Followed by using methods such as hierarchical modelling analysing longitudinal cohort data and creating a clinical trial simulator for disease modifying therapies of Alzheimer’s disease.

Awards: I am funded by the Clarendon Fund and St. Edmund Hall Scholarship.

Thomas, D.X., Bajaj, S., McRae-McKee, K. et al. Association of TDP-43 proteinopathy, cerebral amyloid angiopathy, and Lewy bodies with cognitive impairment in individuals with or without Alzheimer’s disease neuropathology. Sci Rep 10, 14579 (2020). https://doi.org/10.1038/s41598-020-71305-2

Hadjichrysanthou, C., Evans, S., Bajaj, S. et al. The dynamics of biomarkers across the clinical spectrum of Alzheimer’s disease. Alz Res Therapy 12, 74 (2020). https://doi.org/10.1186/s13195-020-00636-z

McRae‐McKee, K., Udeh‐Momoh, C.T., Price, G., Bajaj, S., de Jager, C.A., Scott, D., Hadjichrysanthou, C., McNaughton, E., Bracoud, L., Ahmadi‐Abhari, S., de Wolf, F., Anderson, R.M., Middleton, L.T. and (2019), Perspective: Clinical relevance of the dichotomous classification of Alzheimer's disease biomarkers: Should there be a “gray zone”?. Alzheimer's & Dementia, 15: 1348-1356. doi:10.1016/j.jalz.2019.07.010